Stuttgart - Delayed Quote EUR

Blueprint Medicines Corp (2L9.SG)

Compare
89.90 -0.60 (-0.66%)
As of 8:05 AM GMT+1. Market Open.
Loading Chart for 2L9.SG
DELL
  • Previous Close 90.50
  • Open 89.90
  • Bid 89.86 x --
  • Ask 91.82 x --
  • Day's Range 89.90 - 89.90
  • 52 Week Range 60.50 - 111.05
  • Volume 0
  • Avg. Volume 18
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Feb 13, 2025 - Feb 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 2L9.SG

View More

Performance Overview: 2L9.SG

Trailing total returns as of 11/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

2L9.SG
10.31%
S&P 500
25.15%

1-Year Return

2L9.SG
47.38%
S&P 500
30.93%

3-Year Return

2L9.SG
0.84%
S&P 500
26.97%

5-Year Return

2L9.SG
32.21%
S&P 500
91.92%

Compare To: 2L9.SG

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2L9.SG

View More

Valuation Measures

Annual
As of 11/22/2024
  • Market Cap

    5.71B

  • Enterprise Value

    5.46B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    13.56

  • Price/Book (mrq)

    19.22

  • Enterprise Value/Revenue

    13.16

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 2L9.SG

View More

Company Insights: 2L9.SG

Research Reports: 2L9.SG

View More